V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260012921 | 260013747 | 1.72 | 64.1 | Disease modification (D) | 2016-02-22 | 2016-02-22 | BENDAMUSTINE + RITUXIMAB | N | N | 260024950 | BENDAMUSTINE + RITUXIMAB |
| 260012922 | 260013748 | null | null | Palliative (P) | 2016-08-08 | 2016-08-08 | BEP 3 day | null | N | 260024956 | BEP |
| 260012923 | 260013748 | 1.75 | 90 | Curative (C) | null | 2015-04-30 | BEP 5 Day | 2 | N | 260024956 | BEP |
| 260012924 | 260008041 | 1.89 | 77 | Curative (C) | 2014-07-02 | 2014-07-07 | BEP 3 day | 02 | N | 260024963 | BEP |
| 260012925 | 260008042 | 1.73 | 118.2 | Palliative (P) | 2016-11-12 | 2016-12-20 | BEP 3 day | N | N | 260024964 | BEP |
| 260012926 | 260008042 | 1.73 | 69.5 | Palliative (P) | 2015-12-07 | 2015-12-17 | BEP 5 Day | N | N | 260024964 | BEP |
| 260012927 | 260008043 | 1.66 | 76 | Not known (9) | 2016-09-09 | 2016-10-18 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260024968 | BENDAMUSTINE + RITUXIMAB |
| 260012928 | 260013751 | 1.69 | null | Palliative (P) | 2015-12-12 | 2016-01-30 | Bendamustine+Rituximab (1st Course) | N | N | 260024969 | BENDAMUSTINE + RITUXIMAB |
| 260012929 | 260013751 | 1.61 | 78.2 | Disease modification (D) | 2015-06-28 | 2015-07-08 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260024969 | BENDAMUSTINE + RITUXIMAB |
| 260012930 | 260013751 | 1.65 | 91.5 | Palliative (P) | 2014-09-15 | 2014-10-18 | Bendamustine+Rituximab(Sub Courses) | N | N | 260024969 | BENDAMUSTINE + RITUXIMAB |
| 260012931 | 260013752 | 1.63 | 87.8 | Disease modification (D) | 2017-10-29 | 2017-11-28 | Bendamustine+Rituximab(Sub Courses) | 02 | Y | 260024978 | BENDAMUSTINE + RITUXIMAB |
| 260012932 | 260016564 | 1.63 | 60.9 | Curative (C) | 2014-06-12 | 2014-07-13 | BEP 3 day | 2 | null | 260024979 | BEP |
| 260012933 | 260017964 | 1.69 | 81.6 | null | 2017-12-10 | 2017-12-17 | BEP 3 day | N | N | 260024981 | BEP |
| 260012934 | 260008046 | 1.8 | 74.8 | Palliative (P) | 2017-04-07 | 2017-04-29 | Bendamustine+Rituximab(Sub Courses) | 02 | null | 260024984 | BENDAMUSTINE + RITUXIMAB |
| 260012935 | 260008046 | 1.7 | 93.8 | Not known (9) | 2018-03-23 | 2018-03-24 | Bendamustine+Rituximab(Sub Courses) | N | N | 260024984 | BENDAMUSTINE + RITUXIMAB |
| 260012936 | 260017965 | 1.93 | 0 | Disease modification (D) | 2015-08-01 | 2015-08-23 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024990 | BENDAMUSTINE + RITUXIMAB |
| 260012937 | 260008048 | 1.67 | 94 | Disease modification (D) | 2014-10-23 | 2014-10-24 | Bendamustine+Rituximab(Sub Courses) | N | N | 260024994 | BENDAMUSTINE + RITUXIMAB |
| 260012938 | 260008049 | 1.76 | 90 | Disease modification (D) | 2013-11-02 | 2013-12-07 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260024996 | BENDAMUSTINE + RITUXIMAB |
| 260012939 | 260013756 | 1.7 | 91 | Palliative (P) | 2013-07-20 | 2013-07-21 | BEP 3 day | N | N | 260024996 | BEP |
| 260012940 | 260008050 | null | null | null | 2015-09-12 | 2015-10-08 | BENDAMUSTINE + RITUXIMAB | null | N | 260024999 | BENDAMUSTINE + RITUXIMAB |
| 260012941 | 260008051 | 1.78 | 84 | Adjuvant (A) | 2014-09-13 | 2014-10-03 | BEP 5 Day | 02 | N | 260025000 | BEP |
| 260012942 | 260008052 | 1.59 | 68 | Palliative (P) | 2018-03-03 | 2018-03-31 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260025001 | BENDAMUSTINE + RITUXIMAB |
| 260012943 | 260013759 | 1.75 | 76.1 | Curative (C) | 2015-04-19 | 2015-07-07 | Bendamustine+Rituximab(Sub Courses) | N | null | 260025008 | BENDAMUSTINE + RITUXIMAB |
| 260012944 | 260008053 | 1.64 | 62 | null | 2017-06-08 | 2017-07-11 | BEP 3 day | N | N | 260025011 | BEP |
| 260012945 | 260008054 | 1.73 | 73.6 | Palliative (P) | 2015-11-26 | 2015-11-27 | BEP 5 Day | N | N | 260025012 | BEP |
| 260012946 | 260013760 | 1.77 | 64 | Palliative (P) | 2013-09-05 | 2013-09-06 | BENDAMUSTINE + RITUXIMAB | N | N | 260025013 | BENDAMUSTINE + RITUXIMAB |
| 260012947 | 260016568 | 1.69 | 0 | Curative (C) | 2017-05-11 | 2017-06-30 | BEP 5 Day | 02 | N | 260025017 | BEP |
| 260012948 | 260016568 | 1.8 | 74 | Curative (C) | 2016-06-16 | 2016-06-16 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025017 | BENDAMUSTINE + RITUXIMAB |
| 260012949 | 260008055 | null | null | null | 2018-02-20 | 2018-03-06 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025022 | BENDAMUSTINE + RITUXIMAB |
| 260012950 | 260008055 | 1.83 | 91.7 | Curative (C) | 2017-06-12 | 2017-06-14 | BEP 5 Day | N | N | 260025022 | BEP |
| 260012951 | 260008056 | null | null | Curative (C) | 2014-01-16 | 2014-02-28 | BEP 3 day | 02 | N | 260025031 | BEP |
| 260012952 | 260016570 | 1.83 | 106 | Palliative (P) | 2015-01-09 | 2015-01-10 | BEP 5 Day | 2 | N | 260025032 | BEP |
| 260012953 | 260017967 | 1.63 | 78 | Disease modification (D) | 2015-09-09 | 2015-10-06 | BENDAMUSTINE + RITUXIMAB | N | N | 260025033 | BENDAMUSTINE + RITUXIMAB |
| 260012954 | 260016571 | 1.84 | null | Palliative (P) | 2014-05-05 | 2014-05-20 | BENDAMUSTINE + RITUXIMAB | N | N | 260025033 | BENDAMUSTINE + RITUXIMAB |
| 260012955 | 260016571 | 1.78 | 71.3 | Curative (C) | 2013-10-28 | 2013-11-04 | BEP 3 day | N | N | 260025033 | BEP |
| 260012956 | 260016571 | 1.79 | 117.3 | Palliative (P) | 2013-10-24 | 2013-11-01 | BEP 5 Day | N | N | 260025033 | BEP |
| 260012957 | 260008059 | 1.75 | 94.5 | Curative (C) | 2016-09-01 | 2016-09-06 | BEP 3 day | N | N | 260025041 | BEP |
| 260012958 | 260013764 | 1.79 | 69 | Curative (C) | 2017-10-31 | 2017-11-14 | BEP 5 Day | 02 | N | 260025048 | BEP |
| 260012959 | 260013764 | 1.78 | 105.9 | Disease modification (D) | 2016-05-27 | 2016-06-03 | BENDAMUSTINE + RITUXIMAB | N | N | 260025048 | BENDAMUSTINE + RITUXIMAB |
| 260012960 | 260008060 | 1.64 | 78 | Disease modification (D) | 2016-09-07 | 2016-08-20 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025050 | BENDAMUSTINE + RITUXIMAB |
| 260012961 | 260008061 | 1.53 | 66.6 | Disease modification (D) | 2017-04-12 | 2017-05-30 | BEP 3 day | N | N | 260025051 | BEP |
| 260012962 | 260008061 | 1.57 | 103.4 | Curative (C) | 2017-05-07 | 2017-05-10 | BEP 5 Day | 02 | N | 260025051 | BEP |
| 260012963 | 260008061 | 1.62 | 91.8 | Palliative (P) | 2017-10-15 | 2017-10-23 | BEP 5 Day | N | N | 260025051 | BEP |
| 260012964 | 260008062 | 1.52 | 79 | Disease modification (D) | 2014-04-21 | 2014-04-21 | Bendamustine+Rituximab(Sub Courses) | N | N | 260025072 | BENDAMUSTINE + RITUXIMAB |
| 260012965 | 260008063 | 1.75 | 70 | Disease modification (D) | 2016-12-09 | 2016-12-11 | BENDAMUSTINE + RITUXIMAB | N | N | 260025075 | BENDAMUSTINE + RITUXIMAB |
| 260012966 | 260008064 | 1.59 | 71.1 | Palliative (P) | 2015-06-20 | 2015-06-27 | BENDAMUSTINE + RITUXIMAB | N | N | 260025075 | BENDAMUSTINE + RITUXIMAB |
| 260012967 | 260013769 | 1.69 | 64.4 | Palliative (P) | 2013-12-04 | 2013-12-11 | BEP 5 Day | N | N | 260025076 | BEP |
| 260012968 | 260008066 | 1.81 | 68.8 | Disease modification (D) | 2016-05-21 | 2016-06-25 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260025083 | BENDAMUSTINE + RITUXIMAB |
| 260012969 | 260008066 | null | null | Palliative (P) | 2015-01-28 | 2015-02-11 | BEP 3 day | N | N | 260025083 | BEP |
| 260012970 | 260008068 | 1.77 | 106.8 | Adjuvant (A) | null | 2013-07-16 | BEP 3 day | N | N | 260025085 | BEP |